Daily Med News

Newer Diabetes Drugs, Including GLP-1 Agonists, Tied to Autoimmunity Risk

(MedPage Today) — Analysis of hundreds of thousands of patient records showed differing risks for autoimmune disorders for new users of the more recent types of antidiabetic medications. Rates of new-onset autoimmune conditions were compared…

Source: MedPage Today — Headlines

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]